top of page
NCSCG 2020 Liver Symposium Cvent Email B

2021 Liver Symposium

January 7, 2021

Webinar 1

If claiming CME/MOC, both the post test and evaluation are required.
For more information on CME/MOC offered please click here.

HBV Reactivation

      

Mindie Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine, Professor of Epidemiology and Population Health, Director for the Hepatology Fellowship, Director for the Hepatology Clerkship

Stanford University Medical Center

 

Non-Chronic Hepatidites and Vaccination

Naoky Tsai, MD

Clinical Professor of Medicine

John A Burns School of Medicine

University of Hawaii, Manoa

HCV in Special Populations

Lisa Catalli, NP, MSN

Nurse Practitioner

University of California, San Francisco

January 14, 2021

Webinar 2

If claiming CME/MOC, both the post test and evaluation are required.
For more information on CME/MOC offered please click here.

Practicing Hepatology During a Pandemic

      

Julius Wilder, MD, PhD

Duke University, NC

Impact of COVID on Liver Disease

      

Renu Dhanasekaran, MD

Stanford Medical Center, CA

Management of COVID Patients on Immunosuppression

      

Oren Fix, MD, MSc

Swedish Medical Center, WA

January 21, 2021

Webinar 3

If claiming CME/MOC, both the post test and evaluation are required.
For more information on CME/MOC offered please click here.

Systemic Therapy for HCC Update

      

Tyler Johnson, MD

Stanford Healthcare, CA

HCC and Transplant

      

Neil Mehta, MD

University of California San Francisco, CA

 

Benign Liver Lesions

      

Jennifer Guy, MD, MAS

California Pacific Medical Center, CA

 

January 28, 2021

Webinar 4

If claiming CME/MOC, both the post test and evaluation are required.
For more information on CME/MOC offered please click here.

Management of Portal Hypertension in Patients With and Without Acute Variceal Hemorrhage

      

Dan Sze, MD, PhD

Stanford University Medical Center, CA

 

Ascites and Complications

      

Todd Frederick, MD

California Pacific Medical Center, CA

 

Frailty in Patients with Cirrhosis: From Recognition to Reversal

      

Jennifer Lai, MD, MBA

University of California San Francisco, CA

 

bottom of page